FDA 510(k)
FDA class 2
Substantially Equivalent
🇫🇷 France
MammoScreen® (4)
K Number: K243679
·
Decision Jul 3, 2025
Classifications
1
FEI Numbers
11
Registration Numbers
11
Same Product Code
34
Applicant Total
6
Review Days
216
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- MammoScreen® (4)
- K Number
- K243679
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 892.2090
- Medical Specialty
- Radiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Therapixel
- Date Received
- November 29, 2024
- Decision Date
- July 3, 2025
- Product Code
- QDQ
- Advisory Committee
- Radiology
- Review Advisory Committee
- RA
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QDQ | Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer | FDA class 2 | Radiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (QDQ), ordered by most recent decision date.
Saige-Dx
FDA 510(k)
FDA Class 2
·Radiology
DeepHealth ProstateAI
FDA 510(k)
FDA Class 2
·Radiology
Lunit INSIGHT MMG (v1.1.10)
FDA 510(k)
FDA Class 2
·Radiology
Lunit INSIGHT DBT (V1.2)
FDA 510(k)
FDA Class 2
·Radiology
Median LCS (internal name) / eyonis LCS (trade name) (1.0)
FDA 510(k)
FDA Class 2
·Radiology
Saige-Dx
FDA 510(k)
FDA Class 2
·Radiology
Other Clearances by Therapixel
| K Number | Device Name | ||
|---|---|---|---|
| K243685 | MammoScreen BD | Aug 22, 2025 | Substantially Equivalent |
| K241561 | MammoScreen BD | Oct 2, 2024 | Substantially Equivalent |
| K240301 | MammoScreen® (3) | Aug 1, 2024 | Substantially Equivalent |
| K211541 | MammoScreen 2.0 | Nov 26, 2021 | Substantially Equivalent |
| K192854 | MammoScreen | Mar 25, 2020 | Substantially Equivalent |